Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents.
Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents. Sci Rep. 2018 11 19; 8(1):16970.
View in:
PubMed
subject areas
Adolescent
Adult
Child
Dose-Response Relationship, Drug
Double-Blind Method
Excitatory Amino Acid Antagonists
Female
Fragile X Syndrome
Humans
Indoles
Male
Mental Disorders
Middle Aged
Placebos
Receptor, Metabotropic Glutamate 5
Young Adult
authors with profiles
Elizabeth Berry-Kravis